Last 12 months
Inside the activity.
0 purchase rows · 48 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2024 Filed Feb 16, 2024 21:30 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
GrantCommon Stock | 12,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001946439-24-000002 · wk-form4_1708119020.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,666 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:28 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
GrantCommon Stock | 9,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001938861-24-000006 · wk-form4_1708118895.xml · nonDerivative · entry 2 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,404 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:28 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
GrantCommon Stock | 14,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001938861-24-000006 · wk-form4_1708118895.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,562 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:26 UTC |
CAREY STEPHEN P.SVP & CFO
|
GrantCommon Stock | 14,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001674236-24-000003 · wk-form4_1708118772.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,629 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:26 UTC |
CAREY STEPHEN P.SVP & CFO
|
GrantCommon Stock | 21,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001674236-24-000003 · wk-form4_1708118772.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,313 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 13, 2024 Filed Feb 14, 2024 01:05 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $56.04 | $14,010.00 |
DisclosureSEC source: 0001938861-24-000004 · wk-form4_1707872714.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,799 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| January 23, 2024 Filed Jan 23, 2024 22:32 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 15,000 | $56.44 | $846,600.00 |
DisclosureSEC source: 0001870913-24-000004 · wk-form4_1706049128.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 882,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $56.00 to $57.11, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 22:32 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 5,692 | $55.95 | $318,467.40 |
DisclosureSEC source: 0001870913-24-000004 · wk-form4_1706049128.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 897,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $55.63 to $56.21, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 22:32 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 4,524 | $55.57 | $251,398.68 |
DisclosureSEC source: 0001870913-24-000004 · wk-form4_1706049128.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 903,312 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $55.03 to $56.00, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| January 18, 2024 Filed Jan 18, 2024 23:20 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 9,784 | $55.30 | $541,055.20 |
DisclosureSEC source: 0001870913-24-000002 · wk-form4_1705619998.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 907,836 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.70 to $55.73, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 23:20 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 10,000 | $55.11 | $551,100.00 |
DisclosureSEC source: 0001870913-24-000002 · wk-form4_1705619998.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 917,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.59 to $55.57, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:20 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 5,000 | $55.63 | $278,150.00 |
DisclosureSEC source: 0001870913-24-000002 · wk-form4_1705619998.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 927,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.99 to $56.71, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 02:09 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $56.43 | $14,107.50 |
DisclosureSEC source: 0001938861-24-000002 · wk-form4_1705457345.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,049 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| December 19, 2023 Filed Dec 19, 2023 22:44 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 25,000 | $52.65 | $1,316,250.00 |
DisclosureSEC source: 0001870913-23-000020 · wk-form4_1703025852.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 932,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.45 to $53.19, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 22:44 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 13,026 | $52.44 | $683,083.44 |
DisclosureSEC source: 0001870913-23-000020 · wk-form4_1703025852.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 957,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.02 to $52.97, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:44 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 11,974 | $52.44 | $627,916.56 |
DisclosureSEC source: 0001870913-23-000020 · wk-form4_1703025852.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 970,646 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.97 to $52.97, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| December 11, 2023 Filed Dec 11, 2023 22:49 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $49.21 | $12,302.50 |
DisclosureSEC source: 0001938861-23-000008 · wk-form4_1702334937.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,299 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 02:05 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 13,000 | $51.00 | $663,000.00 |
DisclosureSEC source: 0001870913-23-000018 · wk-form4_1700532348.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 982,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.70 to $51.43, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| November 16, 2023 Filed Nov 16, 2023 23:11 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 6,448 | $51.66 | $333,103.68 |
DisclosureSEC source: 0001870913-23-000013 · wk-form4_1700176267.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 996,430 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.14 to $52.70, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| November 16, 2023 Filed Nov 21, 2023 01:58 UTC Amendment |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 6,448 | $51.66 | $333,103.68 |
DisclosureSEC source: 0001870913-23-000016 · wk-form4a_1700531880.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 995,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.14 to $52.70, inclusive F3 · ownership.nature: The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 23:13 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
SaleCommon Stock | 2,622 | $53.81 | $141,089.82 |
DisclosureSEC source: 0001946439-23-000005 · wk-form4_1700176406.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,587 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $53.80 to $53.91, inclusive. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 23:11 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 7,647 | $53.64 | $410,185.08 |
DisclosureSEC source: 0001870913-23-000013 · wk-form4_1700176267.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,002,878 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.96 to $54.24, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| November 15, 2023 Filed Nov 21, 2023 01:58 UTC Amendment |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 7,647 | $53.64 | $410,185.08 |
DisclosureSEC source: 0001870913-23-000016 · wk-form4a_1700531880.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,002,068 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.96 to $54.24, inclusive. F3 · ownership.nature: The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 23:11 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 22,095 | $53.17 | $1,174,791.15 |
DisclosureSEC source: 0001870913-23-000013 · wk-form4_1700176267.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,010,525 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.95 to $54.07, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| November 14, 2023 Filed Nov 21, 2023 01:58 UTC Amendment |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 22,905 | $53.17 | $1,217,858.85 |
DisclosureSEC source: 0001870913-23-000016 · wk-form4a_1700531880.xml · nonDerivative · entry 1 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,009,715 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.95 to $54.07, inclusive. F3 · ownership.nature: The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 22:04 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $52.03 | $13,007.50 |
DisclosureSEC source: 0001938861-23-000006 · wk-form4_1699999442.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,549 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 21:02 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
SaleCommon Stock | 3,000 | $52.47 | $157,410.00 |
DisclosureSEC source: 0001846487-23-000003 · wk-form4_1699909333.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,607 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.41 to $52.58, inclusive. Read SEC document |
| October 19, 2023 Filed Oct 19, 2023 20:28 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 10,000 | $57.06 | $570,600.00 |
DisclosureSEC source: 0001870913-23-000011 · wk-form4_1697747306.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,032,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $56.50 to $57.69, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| October 18, 2023 Filed Oct 19, 2023 20:28 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 6,242 | $57.78 | $360,662.76 |
DisclosureSEC source: 0001870913-23-000011 · wk-form4_1697747306.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,042,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.15 to $58.41, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| October 17, 2023 Filed Oct 19, 2023 20:28 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 8,758 | $58.53 | $512,605.74 |
DisclosureSEC source: 0001870913-23-000011 · wk-form4_1697747306.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,048,862 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $58.03 to $59.47, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:32 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 13,063 | $58.31 | $761,703.53 |
DisclosureSEC source: 0001870913-23-000009 · wk-form4_1697574720.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,057,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.75 to $58.88, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| October 13, 2023 Filed Oct 17, 2023 20:32 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 11,937 | $57.58 | $687,332.46 |
DisclosureSEC source: 0001870913-23-000009 · wk-form4_1697574720.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,070,683 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.36 to $58.00, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 00:00 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $56.48 | $1,129,600.00 |
DisclosureSEC source: 0001871002-23-000009 · wk-form4_1696377605.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 293,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: Reflects the weighted average price of sales on October 2, 2023. The shares were sold in multiple transactions at prices ranging from $55.90 to $57.66, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| September 19, 2023 Filed Sep 19, 2023 21:14 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 25,333 | $61.23 | $1,551,139.59 |
DisclosureSEC source: 0001870913-23-000007 · wk-form4_1695158086.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,082,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.63 to $61.69, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| September 18, 2023 Filed Sep 19, 2023 21:14 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 8,425 | $61.64 | $519,317.00 |
DisclosureSEC source: 0001870913-23-000007 · wk-form4_1695158086.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,107,953 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $61.23 to $62.94, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 21:14 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 16,242 | $62.81 | $1,020,160.02 |
DisclosureSEC source: 0001870913-23-000007 · wk-form4_1695158086.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,116,378 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.01 to $63.82, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| September 12, 2023 Filed Sep 14, 2023 12:01 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
Tax withholdingCommon Stock | 1,486 | $61.91 | $91,998.26 |
DisclosureSEC source: 0001946439-23-000003 · wk-form4_1694692910.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,209 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,108 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| September 08, 2023 Filed Sep 11, 2023 22:23 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 3,646 | $61.94 | $225,833.24 |
DisclosureSEC source: 0001822629-23-000004 · wk-form4_1694471020.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,744 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,127 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 21:06 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $64.70 | $1,294,000.00 |
DisclosureSEC source: 0001871002-23-000006 · wk-form4_1693947949.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 313,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: Reflects the weighted average price of sales on September 1, 2023. The shares were sold in multiple transactions at prices ranging from $64.18 to $65.26, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 20:29 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 25,000 | $63.37 | $1,584,250.00 |
DisclosureSEC source: 0001870913-23-000005 · wk-form4_1693427333.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,132,620 F3 · price: Reflects the weighted average price of sales on August 29, 2023. The shares were sold in multiple transactions at prices ranging from $62.4877 to $63.92, inclusive. F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| August 28, 2023 Filed Aug 30, 2023 20:29 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 25,000 | $63.06 | $1,576,500.00 |
DisclosureSEC source: 0001870913-23-000005 · wk-form4_1693427333.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,157,620 F1 · price: Reflects the weighted average price of sales on August 28, 2023. The shares were sold in multiple transactions at prices ranging from $62.57 to $64.64, inclusive. F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:22 UTC |
Gutwerg OriSVP, GENERICS
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,502 | $31.49 Strike: $31.49 | $425,177.98 |
DisclosureSEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · derivative · entry 4 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,504 Underlying: Common Stock · 13,502 shares Expires 2031-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total options vested on each of February 15, 2022 and February 15, 2023. 25% of the total options will vest on each of February 15, 2024 and February 15, 2025. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:22 UTC |
Gutwerg OriSVP, GENERICS
|
SaleCommon Stock | 2,059 | $62.39 | $128,461.01 |
DisclosureSEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · nonDerivative · entry 3 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,915 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.32 to $62.50, inclusive. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:22 UTC |
Gutwerg OriSVP, GENERICS
|
SaleCommon Stock | 13,502 | $62.39 | $842,389.78 |
DisclosureSEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,974 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.31 to $62.68, inclusive. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:22 UTC |
Gutwerg OriSVP, GENERICS
|
Exercise / conversionCommon Stock | 13,502 | $31.49 | $425,177.98 |
DisclosureSEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:17 UTC |
Marken James G.SVP OPS & PROD DEV
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,667 | $33.00 Strike: $33.00 | $55,011.00 |
DisclosureSEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · derivative · entry 5 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,667 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total options vested on each of April 1, 2015, April 1, 2016, April 1, 2017, and April 1, 2018. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:17 UTC |
Marken James G.SVP OPS & PROD DEV
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,750 | $40.59 Strike: $40.59 | $152,212.50 |
DisclosureSEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · derivative · entry 4 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2026-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the total options vested on each of April 7, 2017, April 7, 2018, April 7, 2019, and April 7, 2020. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:17 UTC |
Marken James G.SVP OPS & PROD DEV
|
SaleCommon Stock | 3,932 | $63.00 | $247,716.00 |
DisclosureSEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · nonDerivative · entry 3 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,112 Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:17 UTC |
Marken James G.SVP OPS & PROD DEV
|
Exercise / conversionCommon Stock | 1,667 | $33.00 | $55,011.00 |
DisclosureSEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · nonDerivative · entry 2 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:17 UTC |
Marken James G.SVP OPS & PROD DEV
|
Exercise / conversionCommon Stock | 3,750 | $40.59 | $152,212.50 |
DisclosureSEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.